PainReform Ltd. (NASDAQ: PRFX) Stock Information | RedChip

PainReform Ltd. (NASDAQ: PRFX)


$0.53
-0.0186 ( -3.41% ) 63.4K

PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.

Market Data


Open


$0.53

Previous close


$0.55

Volume


63.4K

Market cap


$1.87M

Day range


$0.52 - $0.57

52 week range


$0.43 - $11.55

SEC Fillings


Form Type Description Pages Date
6-k Quarterly Reports 3 Jul 14, 2023
6-k Quarterly Reports 9 Jul 14, 2023
6-k Quarterly Reports 3 Jul 12, 2023

Latest News